Company - Owner

Interpharm Consultancy was founded by Peter Wittner. For more information about me, please see my Curriculum Vitae on another page

Interpharm Consultancy
has been providing advice about the UK generic market and consultancy services to generic manufacturers and distributors since 1997. With a background of 15 years in generics from having worked at Evans Medical, H.N. Norton (now IVAX) and Ranbaxy I have had industry experience at all levels up to Managing Director.

The experience that I have gained over the years, both working for other companies and working for myself, has given me a deep understanding of the differences and similarities between markets. Despite the moves by the European Commission to harmonise markets, many differences remain and will continue to do so for several years yet.

I am therefore particularly well placed to help companies from outside the EU to understand the marketplace that they are trying to enter. In addition, companies within the EU that are interested in the UK market are often surpassed to discover how much this heavily genericised and mature generic market differs from their own domestic market.

These are some of the factors that go towards explaining why I have worked with companies from virtually every Western EU member state as well as manufacturers based in countries such as India, Israel and Turkey.

Indian companies can find out more about my experience of working with India in the attached leaflet.

My other work, writing specialist reports on the generic industry, ensures that I keep my knowledge of the markets, the players, the patents and the legislation all up to date both for the EU and the USA. See the News section to learn more about my latest report

Whatever your generic problem, I can probably help you or, if not, put you in touch with one of my specialist partners who can assist.

Publications

• Paper on “Asia: Threat or Opportunity?” published by Spectrum (Decision Resources Inc), May 2008
• Report: “Indian Generics, 2008-2012: The Growing Threat to Westernised Markets” (Spectra Intelligence), Published: January 2008
• Paper on “Practical Defense Strategies for Combating Generics Competition” published by Spectrum (Decision Resources Inc), July 2007
• An Exploration of Consolidation in the Generics Industry in the Spectrum Pharmaceutical Industry Dynamics series by Decision Resources, December 2005
• US and European Prescription Generic Markets: An Examination of Commercial and Regulatory Contrasts published by Arrowhead Publishers, July 2005
• ”Generics Defence Strategies” published by Business Insights, January 2005
• ”Growth Strategies in Generics” published by Reuters Business Insight, July 2004
• ”The European Generics Outlook” published by Reuters Business Insight, April 2003
• “European Generics Markets” published by Informa Pharmaceuticals, October 2000

Partners/Alliances - for more details of partner companies that can provide specialised services, please see the Links to Partners page

Back to the top of the page